Unbiased AI-powered news
A freelance writer detailed personal withdrawal symptoms after stopping venlafaxine. The account references U.S. Health Secretary Robert F. Kennedy Jr.'s announced campaign to reduce psychiatric drug use.
A freelance writer described severe withdrawal symptoms after attempting to stop venlafaxine, an antidepressant taken for more than a decade. The writer reported daily brain zaps, crying fits, nausea, anxiety and sudden episodes of despair during the second attempt to taper the medication in Australia.
The first attempt, conducted without regular medical access while living in the United States, produced confusion severe enough to mimic stroke symptoms. Five million Australians currently receive mental health-related prescriptions, according to the account.
U.S. Health Secretary's Proposal U.S. Health Secretary Robert F.
Kennedy Jr. announced a campaign to reduce reliance on psychiatric drugs. Measures include forming a technical expert panel to develop clinical guidelines for de-prescribing. The writer stated agreement with the emphasis on regulating these medications and treating them as temporary interventions.
American Psychiatric Association president Theresa Miskimen Rivera told National Public Radio that the approach oversimplifies access problems, noting many patients cannot obtain timely comprehensive care. The writer linked rising antidepressant use to limited availability of talk therapy and broader economic pressures including housing costs and social media effects.
U.S. tariff policy targeting Australia's Pharmaceutical Benefits Scheme and lobbying by pharmaceutical companies.
Single source — no framing comparison available.
nypost.comThe World Health Organization said Tuesday that 80 percent of new cases come from unknown transmission chains. As of Monday, 1,926 infections and 702 deaths have been recorded across three provinces.
New ScientistThe LiBBY trial of purified THC and CBD in a rapid-acting oil showed nearly 90 percent of 120 participants improved after 12 weeks. Results were presented at the Alzheimer’s Association International Conference but have not been peer reviewed.
comicbook.comDisney's live-action remake earned $43 million in the United States and Canada and $52 million internationally over its first three days. The $250 million film finished first at the domestic box office despite falling short of studio estimates.